Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

被引：0
|
作者：
Diab, A. [1 ]
Abdel-Wahab, N. [2 ]
Johnson, D. H. [3 ]
Hailemichael, Y. [1 ]
Foo, W. C. [1 ]
Bentebibel, S-E. [1 ]
Lizee, G. A. [1 ]
Ekmekcioglu, S. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Melanoma Med Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Gen Internal Med & Melanoma Med Oncol, Houston, TX 77030 USA
[3] Ochsner Clin Fdn, Ochsner Med Ctr, New Orleans, LA USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
72P
引用
收藏
页码：S1403 / S1403
页数：1
相关论文
共 50 条
  • [21] Inflammatory myoblastic tumor of the uterus and interleukin-6
    Azuno, Y
    Yaga, K
    Suehiro, Y
    Ariyama, S
    Oga, A
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (03) : 890 - 891
  • [22] Interleukin-6 signaling in osteoblasts promotes osteoclast differentiation
    Palmisano, Biagio
    Chowdhury, Subrata
    Karsenty, Gerard
    Hidalgo, Juan
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 91 - 91
  • [23] Biological significance of interleukin-6 secretion on cancer immunotherapy with interleukin-2
    Lissoni, P
    Fumagalli, L
    Barni, S
    DiFelice, G
    Ardizzoia, A
    Maiorca, F
    Tancini, G
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1996, 12 (3-4): : 49 - 52
  • [24] Interleukin-6 blockade improves autonomic dysfunction in rheumatoid arthritis
    Syngle, Ashit
    Verma, Inderjeet
    Krishan, Pawan
    ACTA REUMATOLOGICA PORTUGUESA, 2015, 40 (01): : 85 - 88
  • [25] Preemptive interleukin-6 blockade in patients with COVID-19
    Lucía Guillén
    Sergio Padilla
    Marta Fernández
    Vanesa Agulló
    José Alberto García
    Guillermo Telenti
    Javier García-Abellán
    Ángela Botella
    Félix Gutiérrez
    Mar Masiá
    Scientific Reports, 10
  • [26] Blockade of interleukin-6 as a possible therapeutic target for AA amyloidosis
    Almenara Tejederas, Marina
    Alonso Garcia, Fabiola
    Aguilera Morales, Wenceslao Adrian
    de la Prada Alvarez, Francisco
    Salgueira Lazo, Mercedes
    NEFROLOGIA, 2022, 42 (01): : 22 - 26
  • [27] Rethinking interleukin-6 blockade for treatment of COVID-19
    Scherger, S.
    Henao-Martinez, A.
    Franco-Paredes, C.
    Shapiro, L.
    MEDICAL HYPOTHESES, 2020, 144
  • [28] Preemptive interleukin-6 blockade in patients with COVID-19
    Guillen, Lucia
    Padilla, Sergio
    Fernandez, Marta
    Agullo, Vanesa
    Garcia, Jose Alberto
    Telenti, Guillermo
    Garcia-Abellan, Javier
    Botella, Angela
    Gutierrez, Felix
    Masia, Mar
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [29] Is Interleukin-6 Receptor Blockade the Holy Grail for Inflammatory Diseases?
    Febbraio, M. A.
    Rose-John, S.
    Pedersen, B. K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (04) : 396 - 398
  • [30] Interleukin-6 blockade to de-couple CTLA-4 blockade colitis from anti-tumor efficacy
    Hailemichael, Yared
    Johnson, Daniel
    Foo, Wai
    Hess, Kenneth
    Haymaker, Cara
    Saberian, Chantal
    Bentebibel, Salah
    Burton, Elizabeth
    Wang, Yinghong
    Woodman, Scott
    Hwu, Patrick
    Diab, Adi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345